Mahkam Zanganeh - Oct 3, 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Signature
/s/ Mahkam Zanganeh
Stock symbol
SMMT
Transactions as of
Oct 3, 2024
Transactions value $
$498,776
Form type
4
Date filed
10/3/2024, 04:54 PM
Previous filing
Sep 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Exercise of in-the-money or at-the-money derivative security $499K +316K +3.19% $1.58 10.2M Oct 3, 2024 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee F1, F2
holding SMMT Common Stock 25.5M Oct 3, 2024 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee F2, F3
holding SMMT Common Stock 50K Oct 3, 2024 Immediate family member F2
holding SMMT Common Stock 31K Oct 3, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -316K -100% $0.00 0 Oct 3, 2024 Common Stock 316K $1.58 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 3, 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase 315,681 shares of the Issuer's common stock at an exercise price of $1.58 per share.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 Includes 489,814 shares that were previously disclosed as directly owned by the reporting person.
F4 Excludes 489,814 shares that are disclosed as indirectly owned by the reporting person through the Mahkam Zanganeh Revocable Trust.